| Literature DB >> 35626306 |
Federica De Muzio1, Carmen Cutolo2, Federica Dell'Aversana3, Francesca Grassi3, Ludovica Ravo4, Marilina Ferrante4, Ginevra Danti5,6, Federica Flammia5, Igino Simonetti7, Pierpaolo Palumbo6,8, Federico Bruno6,9, Luca Pierpaoli10, Roberta Fusco11, Andrea Giovagnoni10, Vittorio Miele5,6, Antonio Barile6,9, Vincenza Granata7.
Abstract
Tumour ablation is a strategy of treatment of hepatic tumours in patients with small hepatocellular carcinoma (HCC) (<3 cm) or in patients unfit for surgical resection. Moreover, tumor ablation can be used as an adjuvant therapy or may be used in association with resection in case of patients with poor functional liver disease. These types of treatment usually could be performed percutaneously under image guidance. The most clinically verified and used ablation modalities are Radiofrequency Ablation (RFA) and microwave ablation (MWA). However, despite both of them are considered minimally invasive techniques, they could be related to post-procedural complications. The International Working Group on Image-Guided Tumor and the Society of Interventional Radiology (SIR) identified major and minor post-ablative complications. Major complications, as vascular complications, occur in 2.2% to 3.1% of cases and include all the high risk pathological conditions which could increase the level of care or result in hospital admission or substantially prolonged hospital stay (SIR classifications C-E). Minor complications, as biliary complications, occur in 5% to 8.9% and include self-limiting conditions that are considered to be of low risk for the patient's outcome. The purpose of this review is to summarise the main pathological ultrasound (US) and Computed Tomography (CT) findings, that may arise after ablative treatment. To simplify the analysis, the pathological pictures are divided according to the site of damage into vascular, biliary and extrahepatic complications.Entities:
Keywords: HCC; MWA; RFA; complications; imaging; metastases
Year: 2022 PMID: 35626306 PMCID: PMC9139664 DOI: 10.3390/diagnostics12051151
Source DB: PubMed Journal: Diagnostics (Basel) ISSN: 2075-4418
Figure 1Woman 65 year at 7-day follow-up after RFA of liver metastases. CT assessment ((A): arterial phase; (B): portal phase and (C): late phase): active bleeding (arrow).
Figure 2Woman 63 year at 1-month follow-up after RFA of liver metastasis. MRI assessment ((A): HASTE T2-W sequence; (B): in phase T1-W sequence and (C): porta phase of contrast study), ablated zone with biliary tree damage (arrow).
Figure 3The same patient of Figure 2, MRI assessment ((A): HASTE T2-W sequence, (B): EOB-Phase of contrast study) after 2-month, arrow shows biloma.
Figure 4Man 74 year at 1-month follow-up after RFA of HCC on VI seg. MRI ((A): HASTE T2-W sequences in axial, in (B): EOB-phase of contrast study in axial plane). The arrow shows bile leak.
Figure 5Woman 58 year at 1-week follow-up after MWA of liver metastasis. MRI assessment US assessment of RFA treated HCC on V segment ((A); arrow). In (B) arrow shows cholecystitis.
Figure 6CT assessment (A,B) of treated HCC on IVa seg: pleural effusion and consolidation (arrow).